docetaxel anhydrous has been researched along with Epiphora in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Etminan, M; Maberley, D; Mikelberg, F; Sodhi, M; Yeung, SN | 1 |
| Contorno, T; McGwin, G; Owsley, C; Vicinanzo, MG | 1 |
| Chan, A; de Boer, RH; Gajdatsy, A; Su, C | 1 |
| Hasebe, S; Ochi, N; Takigawa, N; Yamagishi, T; Yamane, H | 1 |
| Kawara, H; Kawashima, Y; Noguchi, Y; Shimizu, Y; Tamura, Y; Tokuyama, Y; Uchiyama, K | 1 |
| Gillis, A; Leyssens, B; Lobelle, JP; Mombaerts, I; Paridaens, R; Wildiers, H | 1 |
| Estephan, FF; Jones, DV; Lin, JT; Spell, DW | 1 |
| Esmaeli, B | 1 |
| Chang, EL; Tu, AH | 1 |
| Gilboa, M; Haim, N; Miller, B; Tsalic, M; Visel, B | 1 |
| Adinin, R; Amin, S; Arbuckle, R; Banay, R; Do, KA; Esmaeli, B; Rivera, E; Valero, V | 1 |
| Ahmadi, MA; Booser, D; Esmaeli, B; Valero, V | 1 |
| Ahmadi, MA; Arbuckle, R; Booser, D; Delpassand, E; Esmaeli, B; Esteva, F; Hortobagyi, G; Ibrahim, N; Valero, V | 1 |
1 review(s) available for docetaxel anhydrous and Epiphora
| Article | Year |
|---|---|
Management of excessive tearing as a side effect of docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Conjunctivitis; Constriction, Pathologic; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Taxoids | 2005 |
1 trial(s) available for docetaxel anhydrous and Epiphora
| Article | Year |
|---|---|
A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Constriction, Pathologic; Docetaxel; Double-Blind Method; Female; Humans; Lacrimal Apparatus Diseases; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ophthalmic Solutions; Taxoids; Treatment Outcome | 2010 |
11 other study(ies) available for docetaxel anhydrous and Epiphora
| Article | Year |
|---|---|
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Child; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Macular Edema; Middle Aged; Optic Nerve Diseases; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids | 2022 |
The Association Between Taxane Use and Lacrimal Disorders.
Topics: Docetaxel; Humans; Lacrimal Apparatus Diseases; Paclitaxel; Taxoids; United States | 2023 |
Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Docetaxel; Female; Humans; Incidence; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Prevalence; Prospective Studies; Taxoids | 2013 |
Epiphora in lung cancer patients receiving docetaxel: a case series.
Topics: Aged; Antineoplastic Agents; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Middle Aged; Taxoids | 2014 |
[A Retrospective Analysis of Epiphora Due to Docetaxel].
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Middle Aged; Retrospective Studies; Taxoids | 2016 |
Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids | 2003 |
Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
Topics: Antineoplastic Agents, Phytogenic; Botulinum Toxins, Type A; Breast Neoplasms; Docetaxel; Female; Humans; Injections; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Neuromuscular Agents; Palliative Care; Taxoids | 2005 |
Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Male; Middle Aged; Prospective Studies; Taxoids | 2006 |
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Incidence; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Prospective Studies; Severity of Illness Index; Taxoids | 2006 |
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fibrosis; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids; Tears | 2001 |
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids | 2002 |